Cambridge, Mass-based InVivo Therapeutics Holdings Corp announces that Christina Morrison has been appointed to its Board of Directors, effective immediately.
Morrison was most recently senior vice president of finance for Aramark. Prior to that, she was senior vice president of business and financial planning at Merck & Co Inc, and senior vice president and chief financial officer at Wyeth Pharmaceuticals.
In addition, Morrison has been a member of the Board of Overseers of the Tuck School of Business at Dartmouth College since May 2011. She has also been a Member of the Board of Angel Flight East, a non-profit organization, since May 2014, according to a media release from the company.
She received a Bachelor of Science degree in Economics from Wharton School at the University of Pennsylvania in 1989, and an MBA from the Tuck School of Business at Dartmouth College in 1993.
“We are committed to building a world-class Board of Directors with seasoned executives so that we can draw upon their diverse insights and experiences as InVivo continues to succeed and grow,” says Mark Perrin, InVivo’s CEO and chairman, in the release. “The Board is pleased to welcome Christina, and we look forward to benefiting from her impressive background and expertise.”
InVivo Therapeutics Holdings Corp is a research and clinical-stage biomaterials and biotechnology company that focuses on the treatment of spinal cord injuries.
[Source(s): InVivo Therapeutics Holdings Corp, Business Wire]